SEC 13F Intelligence

Solstein Capital, LLC / TEVA

Solstein Capital, LLC’s Teva Pharmaceutical Inds Ltd Position

Does Solstein Capital, LLC own Teva Pharmaceutical Inds Ltd (TEVA)? Yes — 97.6K shares worth $3M (+1.21% of its 13F portfolio) as of Q1 2026, up from 95.1K shares the prior filed quarter.

Position Value
$3M
Q1 2026
Shares
97.6K
% of Portfolio
+1.21%
Quarters Held
4
currently held

Position History TEVA

Reported value by quarter
Q2 ’25: $948,616Q2 ’25Q3 ’25: $2MQ3 ’25Q4 ’25: $3MQ4 ’25Q1 ’26: $3MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 202697.6K$3M+1.21%
Q4 202595.1K$3M+1.19%
Q3 202595.1K$2M+0.44%
Q2 202556.6K$948,616+0.49%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Solstein Capital, LLC’s full portfolio or all institutional holders of TEVA.